|
Concomitant medical products: patient medications include but are not limited to: aspirin, zoloft, digoxin, coreg, amlodapine besylate, nitroglycerine, novolyn, allopurinol, ipratropium albuterol, calcium, mucinex, symbicort, iron, satalol.
|
|
On (b)(6) 2012, this patient underwent endovascular treatment for an abdominal aortic aneurysm and was implanted with gore® excluder® aaa endoprosthesis featuring c3® delivery system.The patient tolerated the procedure.On (b)(6) 2017, follow-up imaging determined an endoleak, the aneurysm diameter was reported to measure 6.8 cm.It was unable to determine if the endoleak was a proximal type i or a type ii endoleak.On (b)(6) 2018, follow-up imaging determined an endoleak persisted; the aneurysm diameter was reported to measure 7.3 cm.It was unable to determine if the endoleak was a proximal type i or a type ii endoleak.On (b)(6) 2018, the patient underwent reintervention.Three angiogram's were performed on the patient however the type and source was inconclusive.A gore® excluder® aortic extender component was placed proximally to extend coverage.Final angiography was unable to determined if the endoleak was resolved.The patient tolerated the procedure.
|